Wolverine Trading’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$42.5K	Buy	+16,100	New	+$31.1K	﹤0.01%	5453
2025 Q1	–	Sell	-24,600	Closed	-$52.9K	–	5035
2024 Q4	$52.9K	Buy	24,600 +4,100	+20%	+$9.56K	﹤0.01%	4975
2024 Q3	$34.4K	Hold	20,500	–	–	﹤0.01%	4585
2024 Q2	$45.5K	Buy	+20,500	New	+$48.2K	﹤0.01%	4230
2023 Q1	–	Sell	-15,000	Closed	-$93K	–	4434
2022 Q4	$93K	Buy	+15,000	New	+$107K	﹤0.01%	3429
2021 Q4	–	Sell	-11,500	Closed	-$143K	–	6141
2021 Q3	$143K	Buy	+11,500	New	+$167K	﹤0.01%	5584
2021 Q2	–	Sell	-14,200	Closed	-$390K	–	6195
2021 Q1	$390K	Buy	+14,200	New	+$419K	﹤0.01%	4086
2020 Q2	–	Sell	-9,800	Closed	-$333K	–	4732
2020 Q1	$333K	Buy	9,800 +2,600	+36%	+$137K	﹤0.01%	3104
2019 Q4	$431K	Sell	7,200 -4,600	-39%	-$207K	﹤0.01%	3208
2019 Q3	$446K	Sell	11,800 -4,600	-28%	-$182K	﹤0.01%	2751
2019 Q2	$763K	Sell	16,400 -4,600	-22%	-$216K	﹤0.01%	2290
2019 Q1	$843K	Buy	21,000 +5,800	+38%	+$260K	﹤0.01%	2252
2018 Q4	$671K	Buy	+15,200	New	+$732K	﹤0.01%	2355
2018 Q3	–	Sell	-61,900	Closed	-$4.48M	–	5156
2018 Q2	$4.48M	Hold	61,900	–	–	0.01%	961
2018 Q1	$4.48M	Buy	61,900 +52,200	+538%	+$3.83M	0.01%	961
2017 Q4	$639K	Buy	9,700 +200	+2%	+$10.8K	﹤0.01%	2713
2017 Q3	$476K	Buy	9,500 +1,800	+23%	+$86.8K	﹤0.01%	2655
2017 Q2	$364K	Buy	+7,700	New	+$283K	﹤0.01%	2765